GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Mytrex Health Technologies Inc (ROCO:4431) » Definitions » ROE %

Mytrex Health Technologies (ROCO:4431) ROE % : -23.62% (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Mytrex Health Technologies ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Mytrex Health Technologies's annualized net income for the quarter that ended in Dec. 2024 was NT$-149 Mil. Mytrex Health Technologies's average Total Stockholders Equity over the quarter that ended in Dec. 2024 was NT$632 Mil. Therefore, Mytrex Health Technologies's annualized ROE % for the quarter that ended in Dec. 2024 was -23.62%.

The historical rank and industry rank for Mytrex Health Technologies's ROE % or its related term are showing as below:

ROCO:4431' s ROE % Range Over the Past 10 Years
Min: -12.92   Med: 3.05   Max: 53.97
Current: -12.75

During the past 13 years, Mytrex Health Technologies's highest ROE % was 53.97%. The lowest was -12.92%. And the median was 3.05%.

ROCO:4431's ROE % is ranked worse than
83.34% of 2953 companies
in the Industrial Products industry
Industry Median: 6.2 vs ROCO:4431: -12.75

Mytrex Health Technologies ROE % Historical Data

The historical data trend for Mytrex Health Technologies's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mytrex Health Technologies ROE % Chart

Mytrex Health Technologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 53.97 -1.55 -10.22 -6.86 -12.92

Mytrex Health Technologies Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -17.49 -5.01 -10.11 -2.31 -23.62

Competitive Comparison of Mytrex Health Technologies's ROE %

For the Specialty Industrial Machinery subindustry, Mytrex Health Technologies's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mytrex Health Technologies's ROE % Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Mytrex Health Technologies's ROE % distribution charts can be found below:

* The bar in red indicates where Mytrex Health Technologies's ROE % falls into.



Mytrex Health Technologies ROE % Calculation

Mytrex Health Technologies's annualized ROE % for the fiscal year that ended in Dec. 2024 is calculated as

ROE %=Net Income (A: Dec. 2024 )/( (Total Stockholders Equity (A: Dec. 2023 )+Total Stockholders Equity (A: Dec. 2024 ))/ count )
=-82.375/( (674.844+600.174)/ 2 )
=-82.375/637.509
=-12.92 %

Mytrex Health Technologies's annualized ROE % for the quarter that ended in Dec. 2024 is calculated as

ROE %=Net Income (Q: Dec. 2024 )/( (Total Stockholders Equity (Q: Jun. 2024 )+Total Stockholders Equity (Q: Dec. 2024 ))/ count )
=-149.28/( (663.952+600.174)/ 2 )
=-149.28/632.063
=-23.62 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2024) net income data. ROE % is displayed in the 30-year financial page.


Mytrex Health Technologies  (ROCO:4431) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=-149.28/632.063
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-149.28 / 1922.106)*(1922.106 / 1236.0945)*(1236.0945 / 632.063)
=Net Margin %*Asset Turnover*Equity Multiplier
=-7.77 %*1.555*1.9557
=ROA %*Equity Multiplier
=-12.08 %*1.9557
=-23.62 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2024 )
=Net Income/Total Stockholders Equity
=-149.28/632.063
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-149.28 / -149.604) * (-149.604 / -88.716) * (-88.716 / 1922.106) * (1922.106 / 1236.0945) * (1236.0945 / 632.063)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9978 * 1.6863 * -4.62 % * 1.555 * 1.9557
=-23.62 %

Note: The net income data used here is two times the semi-annual (Dec. 2024) net income data. The Revenue data used here is two times the semi-annual (Dec. 2024) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Mytrex Health Technologies ROE % Related Terms

Thank you for viewing the detailed overview of Mytrex Health Technologies's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Mytrex Health Technologies Business Description

Traded in Other Exchanges
N/A
Address
No. 545, Section 2, Hezhen North Road, Zhongli District, Taoyuan, TWN, 32060
Mytrex Health Technologies Inc is a Taiwan-based company engaged in the manufacturing of non-woven materials and special medical supplies. It is engaged in the development and production of melt-blown products for the protection of the environment and human health. The company offers products ranging from medical to industrial filtration materials such as various types of filtration media, lab coats or outfits, cabin filtration, vacuum cleaner filter bags, and special medical supplies. Its product categories include meltdown, mammoth bedding, and specialized medical supplies like balloon catheters and coronary stents.

Mytrex Health Technologies Headlines

No Headlines